APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Soft Capsules Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Soft Capsules Drugs Industry Growth and Trends Forecast to 2032

Report ID 17403664012 January 2026111 pages

Choose your research edition.

Industry ResearchSoft Capsules Drugs Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Soft Capsules Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Soft Capsules Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Soft Capsules Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Soft Capsules Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

According to APO Research, the global Soft Capsules Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Soft Capsules Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Soft Capsules Drugs market include GSK, A&Z Pharmaceutical, Atrium Innovations, Blackmores, Boehringer Ingelheim, By-health, Chiesi, Nature Made and Sumitomo Dainippon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Soft Capsules Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Soft Capsules Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Soft Capsules Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Soft Capsules Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Soft Capsules Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Soft Capsules Drugs Market by Company

GSK

A&Z Pharmaceutical

Atrium Innovations

Blackmores

Boehringer Ingelheim

By-health

Chiesi

Nature Made

Sumitomo Dainippon

The Clorox Company

Vertex

AstraZeneca

Roche

Merck

Novartis

Teva

Abbott

Soft Capsules Drugs Segment by Type

Liquid Core Drugs

Semi-solid Core Drugs

Soft Capsules Drugs Segment by Application

Hospital Pharmacy

Retail Pharmacy

Soft Capsules Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Soft Capsules Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Soft Capsules Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Soft Capsules Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Soft Capsules Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Soft Capsules Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Soft Capsules Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Soft Capsules Drugs Market Share by Region (2021-2026) Table 4. Global Soft Capsules Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Soft Capsules Drugs Market Share by Region (2027-2032) Table 6. Global Soft Capsules Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Soft Capsules Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Soft Capsules Drugs Market Size Share by Type (2021-2026) Table 9. Global Soft Capsules Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Soft Capsules Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Soft Capsules Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Soft Capsules Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Soft Capsules Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Soft Capsules Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Soft Capsules Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Soft Capsules Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Soft Capsules Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Soft Capsules Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Soft Capsules Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Soft Capsules Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Soft Capsules Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Soft Capsules Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Soft Capsules Drugs Market Size Share by Application (2021-2026) Table 24. Global Soft Capsules Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Soft Capsules Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Soft Capsules Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Soft Capsules Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Soft Capsules Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Soft Capsules Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Soft Capsules Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Soft Capsules Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Soft Capsules Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Soft Capsules Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Soft Capsules Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Soft Capsules Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Soft Capsules Drugs Industry Trends Table 37. Soft Capsules Drugs Industry Drivers Table 38. Soft Capsules Drugs Industry Opportunities and Challenges Table 39. Soft Capsules Drugs Industry Restraints Table 40. Global Soft Capsules Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Soft Capsules Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Soft Capsules Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Soft Capsules Drugs Key Company Headquarters & Area Served Table 44. Global Soft Capsules Drugs Company, Product Type & Application Table 45. Global Soft Capsules Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Soft Capsules Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. GSK Company Information Table 49. GSK Business Overview Table 50. GSK Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. GSK Soft Capsules Drugs Product Portfolio Table 52. GSK Recent Development Table 53. A&Z Pharmaceutical Company Information Table 54. A&Z Pharmaceutical Business Overview Table 55. A&Z Pharmaceutical Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. A&Z Pharmaceutical Soft Capsules Drugs Product Portfolio Table 57. A&Z Pharmaceutical Recent Development Table 58. Atrium Innovations Company Information Table 59. Atrium Innovations Business Overview Table 60. Atrium Innovations Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Atrium Innovations Soft Capsules Drugs Product Portfolio Table 62. Atrium Innovations Recent Development Table 63. Blackmores Company Information Table 64. Blackmores Business Overview Table 65. Blackmores Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Blackmores Soft Capsules Drugs Product Portfolio Table 67. Blackmores Recent Development Table 68. Boehringer Ingelheim Company Information Table 69. Boehringer Ingelheim Business Overview Table 70. Boehringer Ingelheim Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Boehringer Ingelheim Soft Capsules Drugs Product Portfolio Table 72. Boehringer Ingelheim Recent Development Table 73. By-health Company Information Table 74. By-health Business Overview Table 75. By-health Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. By-health Soft Capsules Drugs Product Portfolio Table 77. By-health Recent Development Table 78. Chiesi Company Information Table 79. Chiesi Business Overview Table 80. Chiesi Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Chiesi Soft Capsules Drugs Product Portfolio Table 82. Chiesi Recent Development Table 83. Nature Made Company Information Table 84. Nature Made Business Overview Table 85. Nature Made Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Nature Made Soft Capsules Drugs Product Portfolio Table 87. Nature Made Recent Development Table 88. Sumitomo Dainippon Company Information Table 89. Sumitomo Dainippon Business Overview Table 90. Sumitomo Dainippon Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Sumitomo Dainippon Soft Capsules Drugs Product Portfolio Table 92. Sumitomo Dainippon Recent Development Table 93. The Clorox Company Company Information Table 94. The Clorox Company Business Overview Table 95. The Clorox Company Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. The Clorox Company Soft Capsules Drugs Product Portfolio Table 97. The Clorox Company Recent Development Table 98. Vertex Company Information Table 99. Vertex Business Overview Table 100. Vertex Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Vertex Soft Capsules Drugs Product Portfolio Table 102. Vertex Recent Development Table 103. AstraZeneca Company Information Table 104. AstraZeneca Business Overview Table 105. AstraZeneca Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. AstraZeneca Soft Capsules Drugs Product Portfolio Table 107. AstraZeneca Recent Development Table 108. Roche Company Information Table 109. Roche Business Overview Table 110. Roche Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Roche Soft Capsules Drugs Product Portfolio Table 112. Roche Recent Development Table 113. Merck Company Information Table 114. Merck Business Overview Table 115. Merck Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Merck Soft Capsules Drugs Product Portfolio Table 117. Merck Recent Development Table 118. Novartis Company Information Table 119. Novartis Business Overview Table 120. Novartis Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Novartis Soft Capsules Drugs Product Portfolio Table 122. Novartis Recent Development Table 123. Teva Company Information Table 124. Teva Business Overview Table 125. Teva Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Teva Soft Capsules Drugs Product Portfolio Table 127. Teva Recent Development Table 128. Abbott Company Information Table 129. Abbott Business Overview Table 130. Abbott Soft Capsules Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Abbott Soft Capsules Drugs Product Portfolio Table 132. Abbott Recent Development Table 133. North America Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. North America Soft Capsules Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. North America Soft Capsules Drugs Market Share by Country (2021-2026) Table 136. North America Soft Capsules Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. North America Soft Capsules Drugs Market Share Forecast by Country (2027-2032) Table 138. Europe Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Soft Capsules Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Soft Capsules Drugs Market Share by Country (2021-2026) Table 141. Europe Soft Capsules Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Soft Capsules Drugs Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Soft Capsules Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Asia-Pacific Soft Capsules Drugs Market Share by Country (2021-2026) Table 146. Asia-Pacific Soft Capsules Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Asia-Pacific Soft Capsules Drugs Market Share Forecast by Country (2027-2032) Table 148. Latin America Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Latin America Soft Capsules Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Latin America Soft Capsules Drugs Market Share by Country (2021-2026) Table 151. Latin America Soft Capsules Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Latin America Soft Capsules Drugs Market Share Forecast by Country (2027-2032) Table 153. Middle East & Africa Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Middle East & Africa Soft Capsules Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Middle East & Africa Soft Capsules Drugs Market Share by Country (2021-2026) Table 156. Middle East & Africa Soft Capsules Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Middle East & Africa Soft Capsules Drugs Market Share Forecast by Country (2027-2032) Table 158. Research Programs/Design for This Report Table 159. Authors List of This Report Table 160. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Soft Capsules Drugs Product Image Figure 3. Global Soft Capsules Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Soft Capsules Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Soft Capsules Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Soft Capsules Drugs Market Share by Region (2021-2032) Figure 7. North America Soft Capsules Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Soft Capsules Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Soft Capsules Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Soft Capsules Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Soft Capsules Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Liquid Core Drugs Image Figure 13. Global Liquid Core Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Semi-solid Core Drugs Image Figure 15. Global Semi-solid Core Drugs Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Soft Capsules Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Soft Capsules Drugs Market Share by Type 2025 VS 2032 Figure 18. North America Soft Capsules Drugs Market Size Share by Type (2021-2032) Figure 19. Europe Soft Capsules Drugs Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Soft Capsules Drugs Market Size Share by Type (2021-2032) Figure 21. Latin America Soft Capsules Drugs Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Soft Capsules Drugs Market Size Share by Type (2021-2032) Figure 23. Hospital Pharmacy Image Figure 24. Global Hospital Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Retail Pharmacy Image Figure 26. Global Retail Pharmacy Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Soft Capsules Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Soft Capsules Drugs Market Share by Application 2025 VS 2032 Figure 29. North America Soft Capsules Drugs Market Size Share by Application (2021-2032) Figure 30. Europe Soft Capsules Drugs Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Soft Capsules Drugs Market Size Share by Application (2021-2032) Figure 32. Latin America Soft Capsules Drugs Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Soft Capsules Drugs Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Soft Capsules Drugs Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Soft Capsules Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Soft Capsules Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Soft Capsules Drugs Market Share by Country (2021-2032) Figure 39. Europe Soft Capsules Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Soft Capsules Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Soft Capsules Drugs Market Share by Country (2021-2032) Figure 42. Asia-Pacific Soft Capsules Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Soft Capsules Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Soft Capsules Drugs Market Share by Country (2021-2032) Figure 45. Latin America Soft Capsules Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Soft Capsules Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Soft Capsules Drugs Market Share by Country (2021-2032) Figure 48. Middle East & Africa Soft Capsules Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Soft Capsules Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Soft Capsules Drugs Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Core Drugs
  • Semi-solid Core Drugs
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • GSK
  • A&Z Pharmaceutical
  • Atrium Innovations
  • Blackmores
  • Boehringer Ingelheim
  • By-health
  • Chiesi
  • Nature Made
  • Sumitomo Dainippon
  • The Clorox Company
  • Vertex
  • AstraZeneca
  • Roche
  • Merck
  • Novartis
  • Teva
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Soft Capsules Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Soft Capsules Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Soft Capsules Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Soft Capsules Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Soft Capsules Drugs Market Size (2021-2032)
  8. 1.5.1 North America Soft Capsules Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Soft Capsules Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Soft Capsules Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Soft Capsules Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Soft Capsules Drugs Market Size Growth Rate (2021-2032)
2 Soft Capsules Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Liquid Core Drugs
  3. 2.1.2 Semi-solid Core Drugs
  4. 2.2 Global Soft Capsules Drugs Market Size by Type
  5. 2.2.1 Global Soft Capsules Drugs Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Soft Capsules Drugs Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Soft Capsules Drugs Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Soft Capsules Drugs Market Size by Regions
  9. 2.3.1 North America Soft Capsules Drugs Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Soft Capsules Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Soft Capsules Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Soft Capsules Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Soft Capsules Drugs Market Size Breakdown by Type (2021-2026)
3 Soft Capsules Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital Pharmacy
  3. 3.1.2 Retail Pharmacy
  4. 3.2 Global Soft Capsules Drugs Market Size by Application
  5. 3.2.1 Global Soft Capsules Drugs Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Soft Capsules Drugs Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Soft Capsules Drugs Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Soft Capsules Drugs Market Size by Regions
  9. 3.3.1 North America Soft Capsules Drugs Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Soft Capsules Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Soft Capsules Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Soft Capsules Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Soft Capsules Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Soft Capsules Drugs Industry Trends
  2. 4.2 Soft Capsules Drugs Industry Drivers
  3. 4.3 Soft Capsules Drugs Industry Opportunities and Challenges
  4. 4.4 Soft Capsules Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Soft Capsules Drugs Revenue (2021-2026)
  2. 5.2 Global Soft Capsules Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Soft Capsules Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Soft Capsules Drugs Company, Product Type & Application
  5. 5.5 Global Soft Capsules Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Soft Capsules Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Soft Capsules Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Soft Capsules Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 GSK Soft Capsules Drugs Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 A&Z Pharmaceutical
  8. 6.2.1 A&Z Pharmaceutical Company Information
  9. 6.2.2 A&Z Pharmaceutical Business Overview
  10. 6.2.3 A&Z Pharmaceutical Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 A&Z Pharmaceutical Soft Capsules Drugs Product Portfolio
  12. 6.2.5 A&Z Pharmaceutical Recent Developments
  13. 6.3 Atrium Innovations
  14. 6.3.1 Atrium Innovations Company Information
  15. 6.3.2 Atrium Innovations Business Overview
  16. 6.3.3 Atrium Innovations Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Atrium Innovations Soft Capsules Drugs Product Portfolio
  18. 6.3.5 Atrium Innovations Recent Developments
  19. 6.4 Blackmores
  20. 6.4.1 Blackmores Company Information
  21. 6.4.2 Blackmores Business Overview
  22. 6.4.3 Blackmores Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Blackmores Soft Capsules Drugs Product Portfolio
  24. 6.4.5 Blackmores Recent Developments
  25. 6.5 Boehringer Ingelheim
  26. 6.5.1 Boehringer Ingelheim Company Information
  27. 6.5.2 Boehringer Ingelheim Business Overview
  28. 6.5.3 Boehringer Ingelheim Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Boehringer Ingelheim Soft Capsules Drugs Product Portfolio
  30. 6.5.5 Boehringer Ingelheim Recent Developments
  31. 6.6 By-health
  32. 6.6.1 By-health Company Information
  33. 6.6.2 By-health Business Overview
  34. 6.6.3 By-health Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 By-health Soft Capsules Drugs Product Portfolio
  36. 6.6.5 By-health Recent Developments
  37. 6.7 Chiesi
  38. 6.7.1 Chiesi Company Information
  39. 6.7.2 Chiesi Business Overview
  40. 6.7.3 Chiesi Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Chiesi Soft Capsules Drugs Product Portfolio
  42. 6.7.5 Chiesi Recent Developments
  43. 6.8 Nature Made
  44. 6.8.1 Nature Made Company Information
  45. 6.8.2 Nature Made Business Overview
  46. 6.8.3 Nature Made Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Nature Made Soft Capsules Drugs Product Portfolio
  48. 6.8.5 Nature Made Recent Developments
  49. 6.9 Sumitomo Dainippon
  50. 6.9.1 Sumitomo Dainippon Company Information
  51. 6.9.2 Sumitomo Dainippon Business Overview
  52. 6.9.3 Sumitomo Dainippon Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Sumitomo Dainippon Soft Capsules Drugs Product Portfolio
  54. 6.9.5 Sumitomo Dainippon Recent Developments
  55. 6.10 The Clorox Company
  56. 6.10.1 The Clorox Company Company Information
  57. 6.10.2 The Clorox Company Business Overview
  58. 6.10.3 The Clorox Company Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 The Clorox Company Soft Capsules Drugs Product Portfolio
  60. 6.10.5 The Clorox Company Recent Developments
  61. 6.11 Vertex
  62. 6.11.1 Vertex Company Information
  63. 6.11.2 Vertex Business Overview
  64. 6.11.3 Vertex Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Vertex Soft Capsules Drugs Product Portfolio
  66. 6.11.5 Vertex Recent Developments
  67. 6.12 AstraZeneca
  68. 6.12.1 AstraZeneca Company Information
  69. 6.12.2 AstraZeneca Business Overview
  70. 6.12.3 AstraZeneca Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 AstraZeneca Soft Capsules Drugs Product Portfolio
  72. 6.12.5 AstraZeneca Recent Developments
  73. 6.13 Roche
  74. 6.13.1 Roche Company Information
  75. 6.13.2 Roche Business Overview
  76. 6.13.3 Roche Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Roche Soft Capsules Drugs Product Portfolio
  78. 6.13.5 Roche Recent Developments
  79. 6.14 Merck
  80. 6.14.1 Merck Company Information
  81. 6.14.2 Merck Business Overview
  82. 6.14.3 Merck Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Merck Soft Capsules Drugs Product Portfolio
  84. 6.14.5 Merck Recent Developments
  85. 6.15 Novartis
  86. 6.15.1 Novartis Company Information
  87. 6.15.2 Novartis Business Overview
  88. 6.15.3 Novartis Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Novartis Soft Capsules Drugs Product Portfolio
  90. 6.15.5 Novartis Recent Developments
  91. 6.16 Teva
  92. 6.16.1 Teva Company Information
  93. 6.16.2 Teva Business Overview
  94. 6.16.3 Teva Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Teva Soft Capsules Drugs Product Portfolio
  96. 6.16.5 Teva Recent Developments
  97. 6.17 Abbott
  98. 6.17.1 Abbott Company Information
  99. 6.17.2 Abbott Business Overview
  100. 6.17.3 Abbott Soft Capsules Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Abbott Soft Capsules Drugs Product Portfolio
  102. 6.17.5 Abbott Recent Developments
7 North America
  1. 7.1 North America Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Soft Capsules Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Soft Capsules Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Soft Capsules Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Soft Capsules Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Soft Capsules Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Soft Capsules Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Soft Capsules Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Soft Capsules Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Soft Capsules Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Soft Capsules Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Soft Capsules Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst